Filing summary
GSK plc filed this Form 6-K as a foreign private issuer for October 2026. The report was issued on 8 October 2026.
Business context and reporting period
GSK describes itself as a global biopharmaceutical company. This filing reports a board appointment; it does not present financial results for a reporting period.
Key financial metrics
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other financial metrics.
Material change and management commentary
Independent Non-Executive Director Wendy Becker was appointed as a Non-Executive Director of Tesco PLC, effective 1 November 2026. The filing provides no financial outlook, management commentary, risk discussion, or contingencies.
Investor verification
- Verify the effective date and details of Wendy Becker’s Tesco PLC directorship.
- Review GSK’s other filings for financial results or disclosures not included in this notice.